| Identification | Back Directory | [Name]
2-[2-(4-ethoxyphenyl)imidazo[1,2-a]benzimidazol-4-yl]-N,N-diethylethanamine dihydrochloride | [CAS]
1219163-50-4 | [Synonyms]
C012 2HCl
C-012 2HCl
C 012 2HCl
C012 Dihydrochloride
C-012 Dihydrochloride
C 012 Dihydrochloride
2-[2-(4-ethoxyphenyl)imidazo[1,2-a]benzimidazol-4-yl]-N,N-diethylethanamine dihydrochloride | [Molecular Formula]
C23H29ClN4O | [MOL File]
1219163-50-4.mol | [Molecular Weight]
412.96 |
| Hazard Information | Back Directory | [Description]
C012 Dihydrochloride is a novel small molecule compound which sensitized BRAF wild-type melanoma cells to vemurafenib. C012 Dihydrochloride significantly reduced melanoma cell viability, with limited toxicity for normal human fibroblasts. |
|
| Company Name: |
PHARMEKS Ltd.
|
| Tel: |
+7 (495) 702-9648 |
| Website: |
www.pharmeks.com |
|